Global Biomarkers Market Size & Trends Report by Product & Service (Consumables, Service, Software), Type (Safety, Efficacy, Validation), Indication (Infectious Diseases, Cancer), Application (Diagnostics, Personalized Medicine), End Users & Regional Forecasts to 2029
The biomarkers market is expected to grow at 11-14% CAGR in the next 5 years. The increased demand for personalized medicine, the rising prevalence of chronic and infectious diseases, the growing demand for early and accurate diagnostics, advancement in biomarkers technologies, the growing importance of companion diagnostics, significant investment in R&D for developing advanced biomarkers, and growing applications of biomarkers in diagnostics are some of the key factors driving the biomarkers market. To learn more about the research report, download a sample report.
Report Overview
Biomarkers are measurable indicators or characteristics that offer insights into different biological processes within the body. They are essential in disease research, as they include molecular changes that support disease diagnosis, treatment monitoring, and drug development. Key types include prognostic, predictive, pharmacodynamic, and exposure-related biomarkers, each playing a critical role in understanding and managing diverse diseases.
To learn more about the research report, download a sample report.
The rising impact of biomarkers in precision healthcare and research fuels its demand
Biomarkers have become indispensable in healthcare and medical research, serving as an early warning system that reveals critical insights into our health. They play a pivotal role across multiple areas of healthcare and research, including:
- Early Disease Detection: Biomarkers serve as silent sentinels, enabling early diagnosis and monitoring of diseases before they become severe. This allows healthcare professionals to intervene proactively, potentially preventing the progression of conditions like cancer, diabetes, and cardiovascular diseases.
- Precision Medicine: Biomarkers are essential for identifying patient-specific disease mechanisms and predicting treatment responses. By analyzing an individual’s unique genetic and molecular profile, healthcare providers can tailor treatment plans, resulting in more targeted, effective therapies with fewer side effects.
- Monitoring Treatment Responses: Biomarkers provide real-time indicators of the body’s response to treatments. By tracking changes in gene expression, protein levels, or metabolic patterns, healthcare professionals can assess therapy effectiveness and make timely adjustments for optimal results.
- Clinical Trials and Drug Development: With drug failure rates as high as 90%, especially for complex conditions like Alzheimer’s disease, reliable biomarkers are critical in drug discovery. In early drug development phases, biomarkers serve as measurable indicators of a treatment's impact, helping researchers identify promising candidates and streamline the often lengthy, resource-intensive clinical trial process.
To learn more about the research report, download a sample report.
Expanding applications of biomarkers in diagnostics drive market growth
The expanding applications of biomarkers in diagnostics are transforming healthcare, providing tools for early detection, personalized treatment, disease monitoring, and improved patient outcomes. As technology advances, new biomarkers are continuously being discovered, further expanding their role in diagnostics across a wide range of diseases and medical fields. While oncology (detecting early signs for better prognosis), has been a major driver of the biomarker market, the applications are expanding into other therapeutic areas, such as neurology (for Alzheimer’s and Parkinson’s diseases), cardiology (for heart failure and cardiovascular risk), diabetes (for blood sugar management and offering insights into how well glucose is controlled over time), and immunology (for autoimmune disorders). Thus, this broadening scope and the increasing demand for precision medicine and early disease intervention are key factors driving the continuous growth of the biomarkers market.
Competitive Landscape Analysis
The global biomarkers market is marked by the presence of innovative and emerging market players such as Abbott Laboratories, Qiagen, Bio-Rad Laboratories, Illumina, BD Biosciences, Siemens Healthineers, Agilent Technologies, Myriad Genetics, Hologic, Pfizer, AstraZeneca, Adaptive Biotechnologies, Biodesix, Exact Science, Thermo Fisher Scientific Inc., and Roche Diagnostics, among others. Some of the key strategies adopted by market players include product innovations, investing in R&D, strategic partnerships, and collaborations.
Report Scope
|
Report Scope |
Details |
|
Base Year Considered |
2023 |
|
Historical Data |
2022 – 2023 |
|
Forecast Period |
2024 – 2029 |
|
Market Drivers |
|
|
Key Market Trends |
|
|
Segment Scope |
Product & Service, Type, Indication, Application, End User |
|
Regional Scope |
|
|
Key Companies Mapped |
Abbott Laboratories, Qiagen, Bio-Rad Laboratories, Illumina, BD Biosciences, Siemens Healthineers, Agilent Technologies, Myriad Genetics, Hologic, Pfizer, AstraZeneca, Adaptive Biotechnologies, Biodesix, Exact Science, Thermo Fisher Scientific Inc., and Roche Diagnostics, among others |
|
Report Highlights |
Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Market Segmentation
This report by Medi-Tech Insights provides the size of the global biomarkers market at the regional- and country level from 2022 to 2029. The report further segments the market based on product and service, type, indication, application, and end user.
- Market Size & Forecast (2022-2029), By Product & Service, USD Million
- Consumables
- Assay Kits
- Reagents & Chemicals
- Columns and Filters
- Services
- Software
- Consumables
- Market Size & Forecast (2022-2029), By Type, USD Million
- Safety Biomarkers
- Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostics Biomarkers
- Validation Biomarkers
- Market Size & Forecast (2022-2029), By Indication, USD Million
- Infectious Diseases
- Cancer
- Cardiovascular Disease
- Neurological Disease
- Immunological Disease
- Other Indication
- Market Size & Forecast (2022-2029), By Application, USD Million
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Clinical Research
- Other Applications
- Market Size & Forecast (2022-2029), By End User, USD Million
- Hospitals & Diagnostics Laboratories
- Clinical Laboratories
- Pharmaceuticals & Biotechnology Companies
- Research & Academic Institutes
- Other End Users
- Market Size & Forecast (2022-2029), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
- North America
Key Strategic Questions Addressed
- What is the market size & forecast of the biomarkers market?
- What are the historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the biomarkers market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2024-2025)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Biomarkers Market Snapshot (2024-2029)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- Market Overview
- Market Dynamics
- Drivers
- Increased demand for personalized medicine
- Rising prevalence of chronic and infectious diseases
- Advancement in biomarkers technologies
- Growing importance of companion diagnostics
- Significant investment in R&D for developing advanced biomarkers
- Growing applications of biomarkers in diagnostics
- Restraints
- Limited biomarker discovery for complex diseases
- High R&D costs for the development of biomarkers
- Technical complexity associated with data set integration
- Opportunities
- Key Market Trends
- Integration of AI and machine learning to analyze large datasets from genomics, proteomics, and clinical data
- Growing adoption of liquid biopsy for early detection and monitoring
- Increased usage of next-generation sequencing (NGS) technology for central to genomic biomarker discovery
- Drivers
- Unmet Market Needs
- Industry Speaks
- Market Dynamics
- Global Biomarkers Market Size & Forecast (2022-2029), By Product & Service, USD Million
- Consumables
- Assay Kits
- Reagents & Chemicals
- Coulums & Filters
- Services
- Software
- Consumables
- Global Biomarkers Market Size & Forecast (2022-2029), By Type, USD Million
- Safety Biomarkers
- Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostics Biomarkers
- Validation Biomarkers
- Global Biomarkers Market Size & Forecast (2022-2029), By Indication, USD Million
- Infectious Diseases
- Cancer
- Cardiovascular Disease
- Neurological Disease
- Immunological Disease
- Other Indication
- Global Biomarkers Market Size & Forecast (2022-2029), By Application, USD Million
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Clinical Research
- Other Applications
- Global Biomarkers Market Size & Forecast (2022-2029), By End User, USD Million
- Hospitals & Diagnostics Laboratories
- Clinical Laboratories
- Pharmaceuticals & Biotechnology Companies
- Research & Academic Institutes
- Other End Users
- Global Biomarkers Market Size & Forecast (2022-2029), By Region, USD Million
- Introduction
- North America Biomarkers Market Size & Forecast (2022-2029), By Country, USD Million
- US
- Market Size & Forecast, By Product & Service (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Canada
- Market Size & Forecast, By Product & Service (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- US
- Europe Biomarkers Market Size & Forecast (2022-2029), By Country, USD Million
- UK
- Market Size & Forecast, By Product & Service (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Germany
- Market Size & Forecast, By Product & Service (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- France
- Market Size & Forecast, By Product & Service (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Italy
- Market Size & Forecast, By Product & Service (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Spain
- Market Size & Forecast, By Product & Service (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Rest of Europe
- Market Size & Forecast, By Product & Service (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- UK
- Asia Pacific (APAC) Biomarkers Market Size & Forecast (2022-2029), By Country, USD Million
- China
- Market Size & Forecast, By Product & Service (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Japan
- Market Size & Forecast, By Product & Service (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- India
- Market Size & Forecast, By Product & Service (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Rest of Asia Pacific
- Market Size & Forecast, By Product & Service (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- China
- Latin America (LATAM) Biomarkers Market Size & Forecast (2022-2029), USD Million
- Market Size & Forecast, By Product & Service (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Middle East & Africa (MEA) Biomarkers Market Size & Forecast (2022-2029), USD Million
- Market Size & Forecast, By Product & Service (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Indication (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2023)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2024)
- New Product Launches
- Partnerships, Agreements, & Collaborations
- Investment in R&D
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles* (Business Overview, Financial Performance**, Products & Services Offered, Recent Developments)
- Abbott Laboratories
- Siemens Healthineers
- Bio-Rad Laboratories
- BD Biosciences
- Thermo Fisher Scientific Inc.
- Qiagen
- Roche Diagnostics
- Agilent Technologies
- Illumina
- Myriad Genetics
- Other Prominent Players
Note: *Indicative list
**For listed companies
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers, Others
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, Business Development Managers, Consultants, Others
Demand Side Stakeholders:
- Hospitals & Diagnostic Laboratories, Clinical Laboratories, Pharmaceuticals & Biotechnology Companies, Academic & Research Institutes, Others
Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts.
Data Triangulation
Research findings derived through secondary sources & internal analysis were validated with Primary Interviews, the Internal Knowledge Repository, and the Company’s Sales Data.
